Semaglutide vs Mounjaro in India: GLP-1 vs Dual GIP/GLP-1 — Price, Efficacy & Which to Choose

Semaglutide from ₹1,290/mo vs Mounjaro at ₹12,000-16,000. Tirzepatide shows 22% weight loss vs 15%. Which is right for your budget and goals in India?

Verdict

Semaglutide generics at ₹1,290-4,200/month offer exceptional value for most Indian patients. Mounjaro (tirzepatide) delivers superior weight loss (~22% vs ~15%) but costs 3-12x more with no generics available. Choose semaglutide for budget; choose Mounjaro only if maximum weight loss is your priority and you can afford the long-term cost.

Key Differences

Drug Class: Semaglutide (Generics) — GLP-1 receptor agonist · Mounjaro (Tirzepatide) — Dual GIP + GLP-1 agonist
Active Molecule: Semaglutide (Generics) — Semaglutide · Mounjaro (Tirzepatide) — Tirzepatide
Monthly Cost: Semaglutide (Generics) — ₹1,290-4,200 · Mounjaro (Tirzepatide) — ₹12,000-16,000
Weight Loss (max dose): Semaglutide (Generics) — ~15.3% (STEP trials) · Mounjaro (Tirzepatide) — ~22.5% (SURMOUNT trials)
HbA1c Reduction: Semaglutide (Generics) — 1.5-1.8% · Mounjaro (Tirzepatide) — 2.0-2.4%
Generic Options: Semaglutide (Generics) — 40+ brands in India · Mounjaro (Tirzepatide) — None (patent protected)